July 6, 2017 | Israeli medical device company, Theranica Bio-electronics, has completed a $6 million Series A funding round led by Lightspeed Venture Partners. The funding will support the regulatory process and mass manufacturing of their wireless and electronic technologies to treat migraines. CEO Alon Ironi founded the company in 2016 with hopes of combining neuromodulation therapy with modern wireless technology.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Israeli Startup Rings Closing Bell At Nasdaq in NYC
March 28, 2024
Israeli, US Companies Unite To Make More Milk From Mushrooms
March 27, 2024
Facebook comments